Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - REVENUE
Revenue HALO - Halozyme Therapeutics, Inc.
1.02 B
LAST VALUE
24.02%
2 YEAR CAGR
38.95%
5 YEAR CAGR
29.71%
10 YEAR CAGR